IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sarissa Capital Management LP

Q3 2016 Holdings

Filed 2016-11-14 | 14 holdings | $99.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Biogen Inc(BIIB)COM09062X103$97.0M310,00097.6%
Abbvie Inc.(ABBV)COM00287Y109$2.0M32,0002.0%
Ariad Pharmaceuticals IncCOM04033A100$175.9K12,850,0000.2%
Medicines CoCOM584688105$66.1K1,752,0000.1%
Array Biopharma Inc(ARRYEUR)COM04269X105$29.0K4,300,0000.0%
Pacira Pharmaceuticals Inc(PCRX)COM695127100$14.7K430,0000.0%
Innoviva Inc(INVA)COM45781M101$11.0K1,000,0000.0%
Intra Cellular Therapies Inc(ITCIEUR)COM46116X101$10.3K675,0000.0%
Aegerion Pharmaceuticals IncCOM00767E102$7.9K2,649,0000.0%
Advaxis IncCOM NEW007624208$6.4K600,0000.0%
Apricus Biosciences IncCOM03832V109$4.9K14,479,0520.0%
Quest Diagnostics Inc(DGX)COM74834L100$4.2K50,0000.0%
Vivus IncCOM928551100$2.9K2,573,9430.0%
Aveo Pharmaceuticals Inc(AVEOEUR)COM053588109$1.8K2,000,0000.0%